HCW Biologics to Execute 1-for-6 Reverse Stock Split on June 30
HCWB has more than doubled off its 52-week low of $0.25.
Summary
HCW Biologics announced a 1-for-6 reverse stock split, which will become effective on June 30. This action follows shareholder approval on June 15 and earlier proxy filings (April 17, April 29) that sought to implement a reverse split to regain compliance with Nasdaq's minimum bid price requirement. The company had previously received a delisting notice in March. While necessary to maintain its exchange listing, reverse stock splits are often perceived negatively as they typically indicate a company's struggle to maintain its share price. The stock will begin trading on a split-adjusted basis on June 30.
At the time of this announcement, HCWB was trading at $1.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8M. The 52-week trading range was $0.25 to $7.35. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.